CN119367282A - 水性组合物 - Google Patents

水性组合物 Download PDF

Info

Publication number
CN119367282A
CN119367282A CN202411276735.7A CN202411276735A CN119367282A CN 119367282 A CN119367282 A CN 119367282A CN 202411276735 A CN202411276735 A CN 202411276735A CN 119367282 A CN119367282 A CN 119367282A
Authority
CN
China
Prior art keywords
aqueous composition
present
salts
container
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202411276735.7A
Other languages
English (en)
Chinese (zh)
Inventor
西本明功
喜多亚希子
林纱衣子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of CN119367282A publication Critical patent/CN119367282A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CN202411276735.7A 2019-12-27 2020-12-25 水性组合物 Pending CN119367282A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019239599 2019-12-27
JP2019-239599 2019-12-27
PCT/JP2020/048835 WO2021132598A1 (ja) 2019-12-27 2020-12-25 水性組成物
CN202080088980.9A CN114867480A (zh) 2019-12-27 2020-12-25 水性组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202080088980.9A Division CN114867480A (zh) 2019-12-27 2020-12-25 水性组合物

Publications (1)

Publication Number Publication Date
CN119367282A true CN119367282A (zh) 2025-01-28

Family

ID=76574720

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202411276735.7A Pending CN119367282A (zh) 2019-12-27 2020-12-25 水性组合物
CN202080088980.9A Pending CN114867480A (zh) 2019-12-27 2020-12-25 水性组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202080088980.9A Pending CN114867480A (zh) 2019-12-27 2020-12-25 水性组合物

Country Status (6)

Country Link
US (1) US20230101139A1 (https=)
EP (2) EP4674401A3 (https=)
JP (2) JP7617031B2 (https=)
CN (2) CN119367282A (https=)
TW (2) TWI889740B (https=)
WO (1) WO2021132598A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
AU2021318236A1 (en) * 2020-07-30 2023-03-09 Rohto Pharmaceutical Co., Ltd. Aqueous composition
WO2024204749A1 (ja) * 2023-03-31 2024-10-03 ロート製薬株式会社 眼科組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5575100B2 (ja) * 2004-12-28 2014-08-20 ロート製薬株式会社 プラノプロフェン含有組成物
US8541426B2 (en) * 2007-07-11 2013-09-24 Pfizer Inc. Pharmaceutical compositions and methods of treating dry eye disorders
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
KR102306276B1 (ko) * 2013-10-21 2021-09-30 니뽄 다바코 산교 가부시키가이샤 안질환의 치료제 또는 예방제
HK1251223A1 (en) 2015-07-07 2019-01-25 Japan Tobacco, Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
KR102728341B1 (ko) * 2015-09-24 2024-11-11 레오 파마 에이/에스 원형탈모증의 치료
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
JP7722931B2 (ja) * 2019-12-27 2025-08-13 ロート製薬株式会社 水性組成物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Also Published As

Publication number Publication date
JPWO2021132598A1 (https=) 2021-07-01
TW202135821A (zh) 2021-10-01
US20230101139A1 (en) 2023-03-30
EP4070796B1 (en) 2025-12-24
EP4674401A2 (en) 2026-01-07
CN114867480A (zh) 2022-08-05
EP4674401A3 (en) 2026-02-25
TW202541813A (zh) 2025-11-01
EP4070796A1 (en) 2022-10-12
EP4070796A4 (en) 2024-01-17
TWI889740B (zh) 2025-07-11
JP2025036714A (ja) 2025-03-14
JP7617031B2 (ja) 2025-01-17
EP4070796C0 (en) 2025-12-24
WO2021132598A1 (ja) 2021-07-01

Similar Documents

Publication Publication Date Title
CN119367282A (zh) 水性组合物
JP6886878B2 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
RS52457B (sr) Praškasta formulacija za valganciklovir
JP2025146991A (ja) 水性組成物
EP3525792A1 (en) Powder for oral suspension containing lamotrigine
EP2005945B1 (en) Oseltamivir phosphate granule and preparation method thereof
TR201901228T4 (tr) Vortioksetin piroglutamat.
EP4176881A1 (en) Aqueous composition
CN111214446A (zh) 一种供注射用法匹拉韦l-精氨酸盐冻干制剂
ES2582012T3 (es) Composiciones farmacéuticas de levetiracetam
HK40115610A (zh) 水性组合物
HK40070455A (zh) 水性组合物
RU2401110C2 (ru) Препарат в форме пеллет с замедленным высвобождением для вертиго
CN104644632A (zh) 含有阿齐沙坦和苯磺酸氨氯地平的口服片剂及其制备方法
PT2919815T (pt) Uma composição farmacêutica contendo um inibidor eca e um bloqueador de canais de cálcio
HK40070460A (en) Aqueous composition
AU2020312840B2 (en) Pharmaceutical composition of imatinib
KR102271862B1 (ko) 리바록사반 함유 경구용 고형제제
JP2019142967A (ja) オルメサルタンのプロドラッグ製剤
EP4534081A1 (en) Ophthalmic composition
WO2024204749A1 (ja) 眼科組成物
TW202317096A (zh) 酮咯酸（ｋｅｔｏｒｏｌａｃ）液體組合物、其製備方法及應用
EA051764B1 (ru) Офтальмологическая композиция, содержащая левофлоксацин и кеторолак, способ ее получения и ее применение
WO2014188729A1 (ja) 経口用組成物
HK40003059B (zh) 含有阿托品的水性组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40115610

Country of ref document: HK